Journal of Human Genetics and Genomics

Published by: Kowsar

Therapeutic Stem Cells and Their Utilization in Multiple Sclerosis Clinical Trials: A Mini Review

Saman Esmaeilnejad 1 , * , Samaneh Dehghan 2 and Mohammad Javan 1
Authors Information
1 Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2 Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Article information
  • Journal of Human Genetics and Genomics: December 31, 2018, 2 (2); e88276
  • Published Online: January 7, 2019
  • Article Type: Review Article
  • Received: December 25, 2018
  • Accepted: January 4, 2019
  • DOI: 10.5812/jhgg.88276

To Cite: Esmaeilnejad S, Dehghan S, Javan M. Therapeutic Stem Cells and Their Utilization in Multiple Sclerosis Clinical Trials: A Mini Review, J Human Gen Genom. 2018 ; 2(2):e88276. doi: 10.5812/jhgg.88276.

Abstract
Copyright © 2019, Journal of Human Genetics and Genomics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Therapeutic Stem Cell and Clinical Trials on Multiple Sclerosis Patients
2. The Hopes and Challenges Ahead of TSCs to Treat Neurodegenerative Diseases
Footnotes
References
  • 1. Lo Furno D, Mannino G, Giuffrida R. Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases. J Cell Physiol. 2018;233(5):3982-99. doi: 10.1002/jcp.26192. [PubMed: 28926091].
  • 2. Chambers BE, Wingert RA. Principles of stem cell biology applied to the kidney A2-orlando, giuseppe. In: Orlando G, Remuzzi G, Williams DF, editors. Kidney transplantation, bioengineering and regeneration. Academic Press; 2017. p. 817-27.
  • 3. Rebulla P, Giordano R. Cell therapy: An evolutionary development of transfusion medicine. Int J Cardiol. 2004;95 Suppl 1:S38-42. doi: 10.1016/S0167-5273(04)90011-3. [PubMed: 15336844].
  • 4. Niżankowski R, Petriczek T, Skotnicki A, Szczeklik A. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation. Kardiologia Polska (Polish Heart Journal). 2005;63(10):351-60.
  • 5. Drouet M, Mourcin F, Grenier N, Delaunay C, Mayol JF, Lataillade JJ, et al. Mesenchymal stem cells rescue CD34+ cells from radiation-induced apoptosis and sustain hematopoietic reconstitution after coculture and cografting in lethally irradiated baboons: Is autologous stem cell therapy in nuclear accident settings hype or reality? Bone Marrow Transplant. 2005;35(12):1201-9. doi: 10.1038/sj.bmt.1704970. [PubMed: 15821761].
  • 6. Slavin S. Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation. Int J Hematol. 2003;78(3):195-207. [PubMed: 14604277].
  • 7. Kumaran V, Benten D, Follenzi A, Joseph B, Sarkar R, Gupta S. Transplantation of endothelial cells corrects the phenotype in hemophilia A mice. J Thromb Haemost. 2005;3(9):2022-31. doi: 10.1111/j.1538-7836.2005.01508.x. [PubMed: 16102109].
  • 8. Inden M, Yanagisawa D, Hijioka M, Kitamura Y. Therapeutic effects of mesenchymal stem cells for parkinson’s disease. Ann Neurodegener Dis. 2016;1(1):1002.
  • 9. Lye KL, Nordin N, Vidyadaran S, Thilakavathy K. Mesenchymal stem cells: From stem cells to sarcomas. Cell Biol Int. 2016;40(6):610-8. doi: 10.1002/cbin.10603. [PubMed: 26992453].
  • 10. Lazarus HM, Gerson SL. The history of stem cell transplantation. Stem Cells in Regenerative Medicine: Science, regulation and business strategies. Wiley-Blackwell; 2015. p. 69-86.
  • 11. Alenzi FQ, Lotfy M, Tamimi WG, Wyse RK. Review: Stem cells and gene therapy. Lab Hematol. 2010;16(3):53-73. doi: 10.1532/LH96.10010. [PubMed: 20858588].
  • 12. Burnight ER, Wiley LA, Mullins RF, Stone EM, Tucker BA. Gene therapy using stem cells. Cold Spring Harb Perspect Med. 2014;5(4). doi: 10.1101/cshperspect.a017434. [PubMed: 25395375]. [PubMed Central: PMC4382729].
  • 13. Andersen J, Pasca SP. Absent forebrain replaced by embryonic stem cells. Nature. 2018;563(7729):44-5. doi: 10.1038/d41586-018-06933-w. [PubMed: 30375499].
  • 14. Minagar A, Jy W, Jimenez JJ, Alexander JS. Multiple sclerosis as a vascular disease. Neurol Res. 2006;28(3):230-5. doi: 10.1179/016164106X98080. [PubMed: 16687046].
  • 15. Rolak LA. MS: the basic facts. Clin Med Res. 2003;1(1):61-2. [PubMed: 15931288]. [PubMed Central: PMC1069024].
  • 16. Leary SM, Thompson AJ. Primary progressive multiple sclerosis : Current and future treatment options. CNS Drugs. 2005;19(5):369-76. doi: 10.2165/00023210-200519050-00001. [PubMed: 15907149].
  • 17. Luessi F, Siffrin V, Zipp F. Neurodegeneration in multiple sclerosis: Novel treatment strategies. Expert Rev Neurother. 2012;12(9):1061-76. quiz 1077. doi: 10.1586/ern.12.59. [PubMed: 23039386].
  • 18. Capello E, Vuolo L, Gualandi F, Van Lint MT, Roccatagliata L, Bonzano L, et al. Autologous haematopoietic stem-cell transplantation in multiple sclerosis: Benefits and risks. Neurol Sci. 2009;30 Suppl 2:S175-7. doi: 10.1007/s10072-009-0144-5. [PubMed: 19882370].
  • 19. Pouya A, Satarian L, Kiani S, Javan M, Baharvand H. Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination. PLoS One. 2011;6(11). e27925. doi: 10.1371/journal.pone.0027925. [PubMed: 22125639]. [PubMed Central: PMC3220701].
  • 20. Pourabdolhossein F, Dehghan S, Demeneix B, Javan M. Nogo receptor blockade enhances subventricular zone’s stem cells proliferation and differentiation in demyelination context. Physiol Pharmacol. 2017;21(3):193-205.
  • 21. Keeler GD, Kumar S, Palaschak B, Silverberg EL, Markusic DM, Jones NT, et al. Gene therapy-induced antigen-specific tregs inhibit neuro-inflammation and reverse disease in a mouse model of multiple sclerosis. Mol Ther. 2018;26(1):173-83. doi: 10.1016/j.ymthe.2017.09.001. [PubMed: 28943274]. [PubMed Central: PMC5762980].
  • 22. Hosseini A, Estiri H, Akhavan Niaki H, Alizadeh A, Abdolhossein Zadeh B, Ghaderian SMH, et al. Multiple sclerosis gene therapy with recombinant viral vectors: Overexpression of IL-4, leukemia inhibitory factor, and IL-10 in wharton's jelly stem cells used in EAE mice model. Cell J. 2017;19(3):361-74. doi: 10.22074/cellj.2017.4497. [PubMed: 28836399]. [PubMed Central: PMC5570402].
  • 23. Medicine NLo. Multiple Sclerosis clinical trials using stem cells. 2018. Available from: https://clinicaltrials.gov/.
  • 24. Leak RK, Zheng P, Ji X, Zhang JH, Chen J. From apoplexy to stroke: Historical perspectives and new research frontiers. Prog Neurobiol. 2014;115:1-5. doi: 10.1016/j.pneurobio.2013.12.003. [PubMed: 24373958].
  • 25. Ding DC, Lin CH, Shyu WC, Lin SZ. Neural stem cells and stroke. Cell Transplant. 2013;22(4):619-30. doi: 10.3727/096368912X655091. [PubMed: 23127719].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments